CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 147 enrolled
Drug / intervention
CA-008 +5 moredrug
Likely dose
Ketorolac 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03599089
NCT03599089Phase 2Completed

A Phase 2, Randomized, Double-blind, Placebo-controlled Safety, Pharmacokinetics and Efficacy Study of CA-008 in Subjects Undergoing Bunionectomy

Concentric Analgesics·interventional·Posted Jul 26, 2018·Updated Aug 11, 2021

In Brief

A Phase 2 clinical trial evaluating CA-008, Placebo, and 4 other interventions for Post-surgical Pain. Completed, enrolled 147 participants across 3 sites.

Detailed Summary

This is a Phase 2, multi-center, randomized, double-blind, placebo-controlled, parallel design study evaluating a single dose of one of three CA-008 dose levels vs. placebo injected during an elective bunionectomy Bunionectomy to assess post-surgical pain management and the need for rescue medication (oxycodone).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedJul 26, 2018
Enrollment StartJul 9, 2018
Primary CompletionOct 10, 2018
Study CompletionOct 23, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.9 years ago

Interventions

CA-008drug

single-dose wound infiltration prior to surgical incision closure

Placebodrug

single-dose wound infiltration prior to surgical incision closure

Ketorolacdrug

30mg IV administered intraoperatively

Acetaminophendrug

1000mg IV administered intraoperatively

Oxycodonedrug

5mg PO prn post-surgery

Bupivacaine Hydrochloridedrug

0.5% infiltration pre-surgery